SELECTing adjuvant treatment in early stage epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer

被引：0
|
作者：
Tabbo, Fabrizio [1 ]
Reale, Maria Lucia [1 ]
Ruffini, Enrico [2 ]
Novello, Silvia [1 ]
Guerrera, Francesco [2 ]
机构：
[1] Univ Torino, Dept Oncol, Turin, Italy
[2] Univ Torino, Dept Surg Sci, Turin, Italy
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷 / 09期
关键词：
TYROSINE KINASE INHIBITORS; ERLOTINIB; PLACEBO;
D O I：
10.21037/atm.2019.03.55
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer
    Van Der Steen, Nele
    Giovannetti, Elisa
    Carbone, Daniela
    Leonetti, Alessandro
    Rolfo, Christian D.
    Peters, Godefridus J.
    CANCER DRUG RESISTANCE, 2018, 1 (04) : 230 - 249
  • [42] The role of aromatase and epidermal growth factor receptor in non-small cell lung cancer
    Kritikou, I.
    Giannopoulou, E.
    Koutras, A.
    Dimitropoulos, K.
    Kalofonos, H.
    EJC SUPPLEMENTS, 2010, 8 (05): : 135 - 135
  • [43] Epidermal growth factor receptor (EGFR) mutation testingin non-small cell lung cancer (NSCLC) patients (pts).
    Sequist, L. V.
    Joshi, V. A.
    Jänne, P. A.
    Fidias, P.
    Muzikansky, A.
    Meyerson, M.
    Haber, D. A.
    Kucherlapati, R.
    Johnson, B. E.
    Lynch, T. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 408S - 408S
  • [44] Epidermal growth factor receptor (EGFR) expression in non-small cell lung carcinoma (NSCLC) and survival
    Salimath, Shivalingaswamy
    Jayaraj, B. S.
    Mahesh, P. A.
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [45] Adjuvant chemotherapy for early stage non-small cell lung cancer
    Patel, Manali L.
    Wakelee, Heather A.
    FRONTIERS IN ONCOLOGY, 2011, 1
  • [46] Small Molecule Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Non Small Cell Lung Cancer Treatment
    Schettino, Clorinda
    Bareschino, Maria Anna
    Maione, Paolo
    Rossi, Antonio
    Ciardiello, Fortunato
    Gridelli, Cesare
    CURRENT CANCER THERAPY REVIEWS, 2007, 3 (04) : 226 - 235
  • [47] Interstitial Lung Disease Induced by Osimertinib for Epidermal Growth Factor Receptor (EGFR) T790M-positive Non-small Cell Lung Cancer
    Matsumoto, Yoshiya
    Kawaguchi, Tomoya
    Yamamoto, Norio
    Sawa, Kenji
    Yoshimoto, Naoki
    Suzumura, Tomohiro
    Watanabe, Tetsuya
    Mitsuoka, Shigeki
    Asai, Kazuhisa
    Kimura, Tatsuo
    Yoshimura, Naruo
    Kuwae, Yuko
    Hirata, Kazuto
    INTERNAL MEDICINE, 2017, 56 (17) : 2325 - 2328
  • [48] Frequency of epidermal growth factor receptor (EGFR) mutations in stage IB-IIIA EGFR mutation positive non-small cell lung cancer (NSCLC) after complete tumour resection
    Tsuboi, M.
    Herbst, R. S.
    John, T.
    Grohe, C.
    Majem, M.
    Goldman, J. W.
    Kim, S-W.
    Yu, C-J.
    Miziara, J. E. A.
    Novello, S.
    Urban, D.
    Akewanlop, C.
    Ozturk, A.
    Quang, B. V.
    Kowalski, D.
    Marmol, D.
    Marotti, M.
    Laus, G.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2019, 30 : 589 - 589
  • [49] The quantification of epidermal growth factor receptor (EGFR) in plasma is a prognostic factor in advanced non-small cell lung cancer (NSCLC) patients
    Camps, C.
    Sirera, R.
    Munoz-Navarro, M.
    Lopez-Vivanco, G.
    Alonso, G.
    Provencio, M.
    Gonzalez-Larriba, J.
    de las Penas, R.
    Taron, M.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC)
    Watanabe, Hiromi
    Ichihara, Eiki
    Kano, Hirohisa
    Ninomiya, Kiichiro
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    INTERNAL MEDICINE, 2017, 56 (16) : 2195 - 2197
12345